6-32829532-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001290043.2(TAP2):​c.1800A>C​(p.Val600Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0508 in 1,613,994 control chromosomes in the GnomAD database, including 2,457 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 387 hom., cov: 32)
Exomes 𝑓: 0.049 ( 2070 hom. )

Consequence

TAP2
NM_001290043.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.01

Publications

8 publications found
Variant links:
Genes affected
TAP2 (HGNC:44): (transporter 2, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014]
TAP2 Gene-Disease associations (from GenCC):
  • MHC class I deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 6-32829532-T-G is Benign according to our data. Variant chr6-32829532-T-G is described in ClinVar as Benign. ClinVar VariationId is 403514.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0972 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAP2NM_001290043.2 linkc.1800A>C p.Val600Val synonymous_variant Exon 11 of 12 ENST00000374897.4 NP_001276972.1 Q03519-1Q5JNW1
TAP2NM_018833.3 linkc.1800A>C p.Val600Val synonymous_variant Exon 11 of 12 NP_061313.2 Q03519-2Q9UP03

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAP2ENST00000374897.4 linkc.1800A>C p.Val600Val synonymous_variant Exon 11 of 12 1 NM_001290043.2 ENSP00000364032.3 Q03519-1
ENSG00000250264ENST00000452392.2 linkc.1800A>C p.Val600Val synonymous_variant Exon 11 of 15 2 ENSP00000391806.2 E7ENX8

Frequencies

GnomAD3 genomes
AF:
0.0642
AC:
9766
AN:
152078
Hom.:
387
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.100
Gnomad AMI
AF:
0.0625
Gnomad AMR
AF:
0.0395
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.0349
Gnomad SAS
AF:
0.0116
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0508
Gnomad OTH
AF:
0.0397
GnomAD2 exomes
AF:
0.0510
AC:
12810
AN:
251306
AF XY:
0.0497
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.0268
Gnomad ASJ exome
AF:
0.0289
Gnomad EAS exome
AF:
0.0319
Gnomad FIN exome
AF:
0.0987
Gnomad NFE exome
AF:
0.0575
Gnomad OTH exome
AF:
0.0510
GnomAD4 exome
AF:
0.0494
AC:
72185
AN:
1461798
Hom.:
2070
Cov.:
39
AF XY:
0.0483
AC XY:
35119
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.104
AC:
3473
AN:
33480
American (AMR)
AF:
0.0283
AC:
1265
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0295
AC:
771
AN:
26130
East Asian (EAS)
AF:
0.0468
AC:
1856
AN:
39700
South Asian (SAS)
AF:
0.0119
AC:
1029
AN:
86248
European-Finnish (FIN)
AF:
0.0981
AC:
5237
AN:
53398
Middle Eastern (MID)
AF:
0.0258
AC:
149
AN:
5768
European-Non Finnish (NFE)
AF:
0.0502
AC:
55787
AN:
1111968
Other (OTH)
AF:
0.0433
AC:
2618
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
3988
7975
11963
15950
19938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2022
4044
6066
8088
10110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0642
AC:
9769
AN:
152196
Hom.:
387
Cov.:
32
AF XY:
0.0654
AC XY:
4863
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0997
AC:
4140
AN:
41508
American (AMR)
AF:
0.0394
AC:
603
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
100
AN:
3472
East Asian (EAS)
AF:
0.0350
AC:
181
AN:
5176
South Asian (SAS)
AF:
0.0120
AC:
58
AN:
4826
European-Finnish (FIN)
AF:
0.101
AC:
1072
AN:
10594
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0508
AC:
3456
AN:
68004
Other (OTH)
AF:
0.0426
AC:
90
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
474
948
1422
1896
2370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0534
Hom.:
437
Bravo
AF:
0.0612
Asia WGS
AF:
0.0260
AC:
93
AN:
3478
EpiCase
AF:
0.0510
EpiControl
AF:
0.0501

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

MHC class I deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TAP2-related disorder Benign:1
Jul 08, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.18
DANN
Benign
0.61
PhyloP100
-5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229527; hg19: chr6-32797309; COSMIC: COSV107494535; COSMIC: COSV107494535; API